Phillip Markham
6Patents
4h-index
18Co-inventors
50Inventor score
Filing activity: Feb 25, 1993 → May 19, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7901690B2 | Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods | Chemistry; Metallurgy | 31 | Expired |
| US5420030A | Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5576000A | Molecular clones of HIV-1 viral strains MH-ST1 and BA-L, and uses thereof | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5869313A | Molecular clones of HIV-1 viral strains MN-ST1 and BA-L, and uses thereof | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6548631B1 | Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection | Human Necessities | 1 | Expired |
| US8524252B2 | Temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.